Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of hematopoietic
cellular therapy (HCT). This study aimed to evaluate the effect of DAH treatments on …

Background Diffuse alveolar hemorrhage (DAH) is an uncommon complication of
hematopoietic stem cell transplantation (HCT) that carries high morbidity and mortality …

Pulmonary complications are common following hematopoietic cell transplantation (HCT)
and contribute significantly to its morbidity and mortality. Diffuse alveolar hemorrhage is a …

Pulmonary complications post‐hematopoietic stem cell transplantation (HSCT) such as
diffuse alveolar hemorrhage (DAH) can occur in 2% to 14% of HSCT patients and have a …

Diffuse alveolar hemorrhage (DAH) is a morbid syndrome that occurs after autologous and
allogeneic hematopoietic cell transplantation in children and adults. DAH manifests most …

Diffuse alveolar haemorrhage (DAH) is a life-threatening pulmonary complication occurring
after allogeneic haematopoietic stem cell transplantation (allo-HSCT) without an explicit …

Introduction: Diffuse alveolar hemorrhage (DAH) is an early pulmonary complication of
hematopoietic cell transplantation (HCT) associated with severe hypoxemic respiratory …

Background Diffuse alveolar hemorrhage (DAH) is a frequent life-threatening complication
of bone marrow transplantation (BMT) in adults. This noninfectious pulmonary disorder is …

Diffuse alveolar hemorrhage (DAH) is a noninfectious pulmonary complication of
hematopoietic stem cell transplantation (HSCT) with unclear pathogenesis and treatment …

Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation is a frequently
fatal complication with no standard therapy. Although significant changes in supportive and …